In the past week, EOLS stock has gone up by 37.55%, with a monthly gain of 14.92% and a quarterly plunge of -18.94%. The volatility ratio for the week is 7.84%, and the volatility levels for the last 30 days are 5.74% for Evolus Inc The simple moving average for the past 20 days is 24.61% for EOLS’s stock, with a 1.47% simple moving average for the past 200 days.
Is It Worth Investing in Evolus Inc (NASDAQ: EOLS) Right Now?
The stock has a 36-month beta value of 1.31. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for EOLS is 54.70M, and at present, short sellers hold a 9.87% of that float. On January 22, 2025, the average trading volume of EOLS was 623.71K shares.
EOLS) stock’s latest price update
The stock price of Evolus Inc (NASDAQ: EOLS) has jumped by 28.26 compared to previous close of 10.51. Despite this, the company has seen a gain of 37.55% in its stock price over the last five trading days. businesswire.com reported 2025-01-21 that NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today announced its preliminary, unaudited net revenue for the fourth quarter and full-year ended December 31, 2024. The preliminary unaudited results described in this press release are based on the most current information available to management and are subject to change until the audit of the company’s 2024 financial results is completed a.
Analysts’ Opinion of EOLS
Many brokerage firms have already submitted their reports for EOLS stocks, with Barclays repeating the rating for EOLS by listing it as a “Overweight.” The predicted price for EOLS in the upcoming period, according to Barclays is $16 based on the research report published on January 29, 2024 of the previous year 2024.
Needham, on the other hand, stated in their research note that they expect to see EOLS reach a price target of $18. The rating they have provided for EOLS stocks is “Buy” according to the report published on June 23rd, 2022.
Barclays gave a rating of “Equal Weight” to EOLS, setting the target price at $10 in the report published on May 12th of the previous year.
EOLS Trading at 12.85% from the 50-Day Moving Average
After a stumble in the market that brought EOLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.35% of loss for the given period.
Volatility was left at 5.74%, however, over the last 30 days, the volatility rate increased by 7.84%, as shares surge +21.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.25% lower at present.
During the last 5 trading sessions, EOLS rose by +37.55%, which changed the moving average for the period of 200-days by -0.74% in comparison to the 20-day moving average, which settled at $10.82. In addition, Evolus Inc saw 22.10% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EOLS starting from Avelar Rui, who sale 2,252 shares at the price of $10.85 back on Dec 23 ’24. After this action, Avelar Rui now owns 366,595 shares of Evolus Inc, valued at $24,438 using the latest closing price.
Beaver Sandra, the Chief Financial Officer of Evolus Inc, sale 1,586 shares at $10.85 during a trade that took place back on Dec 23 ’24, which means that Beaver Sandra is holding 146,916 shares at $17,211 based on the most recent closing price.
Stock Fundamentals for EOLS
Current profitability levels for the company are sitting at:
- -0.14 for the present operating margin
- 0.68 for the gross margin
The net margin for Evolus Inc stands at -0.22. The total capital return value is set at -0.2. Equity return is now at value -861.68, with -27.90 for asset returns.
Based on Evolus Inc (EOLS), the company’s capital structure generated 0.6 points at debt to capital in total, while cash flow to debt ratio is standing at -2.54. The debt to equity ratio resting at 1.47. The interest coverage ratio of the stock is -1.86.
Currently, EBITDA for the company is -41.81 million with net debt to EBITDA at 1.87. When we switch over and look at the enterprise to sales, we see a ratio of 3.13. The receivables turnover for the company is 5.56for trailing twelve months and the total asset turnover is 1.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.47.
Conclusion
To sum up, Evolus Inc (EOLS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
